Incyte (INCY)
Incyte on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-commercial physical & biological research.
10.0M
Short interest
settlement 2026-09-30
6.1
Days to cover
-1.2 days vs prior
68.3%
Short share of volume
2026-10-09
62,826
Fails to deliver
settlement 2026-09-10
Tue 27 Oct
Next earnings
estimated date
-$18.2M
Insider flow, 90 days
0 buys, 22 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in INCY is 9,987,084 shares, up 622,397 shares over the last month. Over the last 48 readings it ranged from 5,038,309 shares (15 January 2025) to 11,974,587 shares (15 April 2026). At the reported average volume of 1.6M shares a day that is 6.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/incy" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 9,987,084 | +0.1% | 1,647,341 | 6.06 |
| 2026-09-15 | 9,981,369 | +6.6% | 1,375,488 | 7.26 |
| 2026-08-31 | 9,364,687 | -0.3% | 1,218,321 | 7.69 |
| 2026-08-14 | 9,389,500 | -8.4% | 1,408,837 | 6.66 |
| 2026-07-31 | 10,246,477 | -2.5% | 2,134,352 | 4.80 |
| 2026-07-15 | 10,512,123 | -0.6% | 1,630,669 | 6.45 |
| 2026-06-30 | 10,579,770 | +0.2% | 2,196,171 | 4.82 |
| 2026-06-15 | 10,560,807 | -7.4% | 2,230,015 | 4.74 |
| 2026-05-29 | 11,402,307 | +3.3% | 1,236,570 | 9.22 |
| 2026-05-15 | 11,040,495 | -2.8% | 1,276,205 | 8.65 |
| 2026-04-30 | 11,358,353 | -5.2% | 1,610,618 | 7.05 |
| 2026-04-15 | 11,974,587 | +4.6% | 1,223,307 | 9.79 |
| 2026-03-31 | 11,444,784 | +3.6% | 1,731,727 | 6.61 |
| 2026-03-13 | 11,044,905 | +0.3% | 1,577,557 | 7.00 |
| 2026-02-27 | 11,013,719 | +0.0% | 1,610,162 | 6.84 |
| 2026-02-13 | 11,008,853 | -1.7% | 2,147,638 | 5.13 |
| 2026-01-30 | 11,194,591 | +3.7% | 1,695,151 | 6.60 |
| 2026-01-15 | 10,795,109 | +2.4% | 2,372,871 | 4.55 |
| 2025-12-31 | 10,539,631 | -2.0% | 1,798,261 | 5.86 |
| 2025-12-15 | 10,754,723 | +17.6% | 2,339,941 | 4.60 |
| 2025-11-28 | 9,149,380 | -3.6% | 1,873,652 | 4.88 |
| 2025-11-14 | 9,495,529 | -0.2% | 2,723,278 | 3.49 |
| 2025-10-31 | 9,517,258 | +1.6% | 2,786,196 | 3.42 |
| 2025-10-15 | 9,364,129 | +10.1% | 1,517,197 | 6.17 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of INCY volume is 68.3%, down 2.3 points over the last five sessions. Over the last 30 readings it ranged from 46.1% (8 September 2026) to 80.6% (6 October 2026). The latest reading is 3.2 points above the 30-session average of 65.1%, on 459K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 314K | 459K | 68.3% | 66 |
| 2026-10-08 | 497K | 775K | 64.2% | 531 |
| 2026-10-07 | 410K | 534K | 76.8% | 0 |
| 2026-10-06 | 1.1M | 1.3M | 80.6% | 372 |
| 2026-10-05 | 460K | 724K | 63.6% | 308 |
| 2026-10-02 | 574K | 813K | 70.6% | 8,396 |
| 2026-10-01 | 673K | 1.1M | 64.1% | 4,495 |
| 2026-09-30 | 336K | 502K | 66.9% | 1,372 |
| 2026-09-29 | 434K | 599K | 72.5% | 61,361 |
| 2026-09-28 | 342K | 557K | 61.3% | 1,027 |
| 2026-09-25 | 322K | 458K | 70.4% | 176 |
| 2026-09-24 | 276K | 434K | 63.6% | 9,486 |
| 2026-09-23 | 245K | 459K | 53.3% | 3,542 |
| 2026-09-22 | 293K | 462K | 63.3% | 753 |
| 2026-09-21 | 275K | 419K | 65.6% | 3,657 |
| 2026-09-18 | 419K | 527K | 79.6% | 4,832 |
| 2026-09-17 | 261K | 388K | 67.3% | 2,076 |
| 2026-09-16 | 334K | 479K | 69.7% | 119 |
| 2026-09-15 | 242K | 440K | 55.0% | 509 |
| 2026-09-14 | 331K | 440K | 75.3% | 42 |
| 2026-09-11 | 344K | 503K | 68.4% | 632 |
| 2026-09-10 | 585K | 779K | 75.1% | 28,954 |
| 2026-09-09 | 302K | 438K | 69.1% | 1,669 |
| 2026-09-08 | 213K | 462K | 46.1% | 2,056 |
| 2026-09-04 | 206K | 311K | 66.3% | 207 |
| 2026-09-03 | 164K | 309K | 53.0% | 0 |
| 2026-09-02 | 535K | 1.1M | 48.1% | 1,499 |
| 2026-09-01 | 217K | 459K | 47.2% | 5,295 |
| 2026-08-31 | 207K | 373K | 55.5% | 200 |
| 2026-08-28 | 332K | 463K | 71.9% | 1,821 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 10 September 2026, the fails-to-deliver balance in INCY is 62,826 shares, down 651 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (17 July 2026) to 125,375 shares (10 June 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-10 | 62,826 | $126.01 | $7.9M |
| 2026-09-09 | 63,477 | $124.40 | $7.9M |
| 2026-09-08 | 95,688 | $126.75 | $12.1M |
| 2026-09-03 | 1,042 | $128.83 | $134K |
| 2026-09-01 | 2 | $123.22 | $246 |
| 2026-08-31 | 7 | $124.37 | $871 |
| 2026-08-24 | 1,327 | $127.81 | $170K |
| 2026-08-11 | 951 | $121.55 | $116K |
| 2026-08-04 | 1,036 | $118.43 | $123K |
| 2026-08-03 | 1,890 | $119.52 | $226K |
| 2026-07-31 | 11,788 | $122.99 | $1.4M |
| 2026-07-22 | 551 | $117.39 | $65K |
| 2026-07-17 | 1 | $116.65 | $117 |
| 2026-07-01 | 441 | $113.36 | $50K |
| 2026-06-30 | 4,708 | $114.66 | $540K |
| 2026-06-29 | 439 | $113.75 | $50K |
| 2026-06-25 | 4 | $108.46 | $434 |
| 2026-06-24 | 293 | $104.40 | $31K |
| 2026-06-15 | 1,056 | $108.53 | $115K |
| 2026-06-12 | 1,213 | $107.83 | $131K |
| 2026-06-11 | 9,695 | $105.39 | $1.0M |
| 2026-06-10 | 125,375 | $103.23 | $12.9M |
| 2026-05-22 | 4 | $97.41 | $390 |
| 2026-05-20 | 98,488 | $95.60 | $9.4M |
| 2026-05-14 | 25 | $98.82 | $2K |
| 2026-05-07 | 5 | $99.85 | $499 |
| 2026-04-29 | 189 | $97.74 | $18K |
| 2026-04-27 | 52 | $94.65 | $5K |
| 2026-04-24 | 2,550 | $95.47 | $243K |
| 2026-04-23 | 5 | $96.74 | $484 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at INCY reported 22 open-market sells worth $18.2M in the last 90 days and no open-market buys. Latest filing: Heeson Lee (EVP, Head of Incyte Intl) on 2026-10-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Heeson Lee | EVP, Head of Incyte Intl | Tax withholding | 463 | $117.14 | $54K | 38K |
| 2026-09-30 | HARRIGAN EDMUND | Director | Grant | 206 | $121.35 | $25K | 23K |
| 2026-09-30 | Clancy Paul J | Director | Grant | 203 | $121.35 | $25K | 26K |
| 2026-09-30 | BAKER BROS. ADVISORS LP | Director, 10% owner | Grant | 322 | $0.00 | $0 | 2.8M |
| 2026-09-22 | Gardner David H | EVP, Chief Strategy Officer | Tax withholding | 920 | $126.93 | $117K | 16K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 14K | $120.49 | $1.7M | 183K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 9K | $120.50 | $1.1M | 197K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Option exercise | 9K | $71.93 | $664K | 206K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Option exercise | 6K | $64.25 | $416K | 197K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Option exercise | 5K | $61.18 | $278K | 191K |
| 2026-09-15 | CAGNONI PABLO J | President, Global Head of R&D | Option exercise | 3K | $61.76 | $183K | 186K |
| 2026-08-25 | Basi Ramitpal K | EVP, Human Resources | Tax withholding | 504 | $129.72 | $65K | 11K |
| 2026-08-19 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 11K | $125.56 | $1.4M | 183K |
| 2026-08-12 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 11K | $120.04 | $1.3M | 194K |
| 2026-08-05 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2K | $123.99 | $274K | 61K |
| 2026-08-05 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $106.47 | $235K | 64K |
| 2026-08-05 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 11K | $122.69 | $1.3M | 205K |
| 2026-08-03 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6K | $120.43 | $729K | 61K |
| 2026-08-03 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 6K | $105.43 | $638K | 67K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $83.58 | $219K | 99K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2K | $119.41 | $274K | 61K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 326 | $121.69 | $40K | 64K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 85 | $122.19 | $10K | 64K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2K | $119.38 | $196K | 64K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2K | $119.51 | $196K | 66K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 3K | $119.40 | $342K | 67K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5K | $119.39 | $561K | 70K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6K | $119.43 | $737K | 75K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2K | $119.47 | $261K | 81K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5K | $119.42 | $637K | 83K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 15K | $119.46 | $1.8M | 89K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 326 | $105.43 | $34K | 103K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 85 | $106.47 | $9K | 103K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $90.56 | $208K | 103K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $85.01 | $140K | 101K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $83.20 | $252K | 96K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $80.50 | $132K | 93K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $77.67 | $222K | 92K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $74.78 | $196K | 89K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 9K | $72.27 | $684K | 86K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $71.93 | $149K | 77K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $68.62 | $216K | 75K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $61.76 | $167K | 72K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 2K | $64.25 | $147K | 69K |
| 2026-07-31 | Mayes Patrick A | EVP & Chief Scientific Officer | Option exercise | 3K | $61.18 | $179K | 67K |
| 2026-07-31 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 16K | $119.70 | $1.9M | 215K |
| 2026-07-16 | Mayes Patrick A | EVP & Chief Scientific Officer | Grant | 6K | $0.00 | $0 | 64K |
| 2026-07-16 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Grant | 8K | $0.00 | $0 | 72K |
| 2026-07-16 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sell | 1K | $115.01 | $126K | 64K |
| 2026-07-16 | Tray Thomas | Principal Accounting Officer | Grant | 3K | $0.00 | $0 | 22K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for INCY worth $109.2M at the prices reported; 11 in the last 90 days worth $18.2M. Latest: PABLO CAGNONI filed on 2026-09-15 to sell 23,218 shares ($2.8M) from 2026-09-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-15 | PABLO CAGNONIOfficer | 23K | $2.8M | 0.011% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | PABLO CAGNONIOfficer | 11K | $1.4M | 0.005% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-12 | PABLO CAGNONIOfficer | 11K | $1.3M | 0.005% | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-05 | PATRICK A MAYESOfficer | 2K | $274K | 0.001% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-05 | PABLO CAGNONIOfficer | 11K | $1.3M | 0.005% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | PATRICK A MAYESOfficer | 6K | $729K | 0.003% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-31 | PATRICK A MAYESOfficer | 42K | $5.0M | 0.021% | 2026-07-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-31 | PABLO CAGNONIOfficer | 16K | $1.9M | 0.008% | 2026-07-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-16 | STEVEN STEINOfficer | 2K | $215K | 0.001% | 2026-07-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-16 | MOHAMED ISSAOfficer | 1K | $126K | 0.001% | 2026-07-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | STEVEN STEINOfficer | 28K | $3.2M | 0.014% | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | THOMAS R TRAYOfficer | 3K | $264K | 0.001% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-26 | THOMAS R TRAYOfficer | 2K | $200K | 0.001% | 2026-05-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-19 | PAUL J. CLANCYDirector | 15K | $1.4M | 0.008% | 2026-05-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-17 | PABLO CAGNONIOfficer | 19K | $1.8M | 0.009% | 2026-04-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-17 | PABLO CAGNONIOfficer | 19K | $1.8M | 0.009% | 2026-03-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-19 | PABLO CAGNONIOfficer | 19K | $1.9M | 0.009% | 2026-02-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-09 | VIJAY IYENGAROfficer | 13K | $1.4M | 0.006% | 2026-02-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-07 | MOHAMED ISSAOfficer | 11K | $1.2M | 0.006% | 2026-01-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-06 | VIJAY IYENGAROfficer | 96K | $10.0M | 0.049% | 2026-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-05 | VIJAY IYENGAROfficer | 16K | $1.7M | 0.008% | 2026-01-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-05 | STEVEN STEINOfficer | 16K | $1.6M | 0.008% | 2026-01-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-19 | VIJAY IYENGAROfficer | 53K | $5.4M | 0.027% | 2025-12-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-19 | THOMAS R TRAYOfficer | 3K | $277K | 0.001% | 2025-12-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-18 | THOMAS R TRAYOfficer | 600 | $59K | 0.000% | 2025-12-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-17 | MICHAEL MORRISSEYOfficer | 4K | $420K | 0.002% | 2025-12-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | VIJAY IYENGAROfficer | 13K | $1.3M | 0.007% | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | MICHAEL MORRISSEYOfficer | 54K | $5.3M | 0.028% | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | CHRISTIANA STAMOULISOfficer | 188K | $18.2M | 0.096% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | PATRICK A MAYESOfficer | 255 | $24K | 0.000% | 2025-12-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-10 | VIJAY IYENGAROfficer | 23K | $2.2M | 0.012% | 2025-12-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-10 | PATRICK A MAYESOfficer | 6K | $531K | 0.003% | 2025-12-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-02 | STEVEN STEINOfficer | 20K | $2.1M | 0.010% | 2025-12-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-01 | STEVEN STEINOfficer | 3K | $263K | 0.001% | 2025-12-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-24 | THOMAS R TRAYOfficer | 600 | $62K | 0.000% | 2025-11-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-21 | THOMAS R TRAYOfficer | 169 | $17K | 0.000% | 2025-11-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | SHEILA DENTONOfficer | 278 | $29K | 0.000% | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | CHRISTIANA STAMOULISOfficer | 7K | $811K | 0.004% | 2025-11-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-10 | HERVE HOPPENOTOfficer, Director | 188K | $19.8M | 0.096% | 2025-11-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | STEVEN STEINOfficer | 5K | $535K | 0.003% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-04 | SHEILA DENTONOfficer | 598 | $61K | 0.000% | 2025-11-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-03 | CHRISTIANA STAMOULISOfficer | 22K | $2.2M | 0.011% | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-03 | LEE HEESONOfficer | 3K | $289K | 0.002% | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-30 | CHRISTIANA STAMOULISOfficer | 15K | $1.4M | 0.008% | 2025-10-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-27 | BARRY FLANNELLYOfficer | 33K | $3.1M | 0.017% | 2025-10-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-16 | BARRY FLANNELLYOfficer | 18K | $1.7M | 0.009% | 2025-10-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-15 | SHEILA DENTONOfficer | 277 | $24K | 0.000% | 2025-10-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-03 | SHEILA DENTONOfficer | 4K | $299K | 0.002% | 2025-10-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-02 | SHEILA DENTONOfficer | 599 | $53K | 0.000% | 2025-10-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-18 | BARRY FLANNELLYOfficer | 17K | $1.5M | 0.009% | 2025-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON8 holders report 5% or more of INCY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Felix J. Baker at 15.6% of the class (31,225,572 shares), filed 2026-05-11 for an event on 2026-05-07.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-14 | 13G/Ano. 3 | Dodge & Coxinvestment adviser | 12.3M | 6.2% | 2026-03-31 |
| 2026-05-11 | 13D/Ano. 33 | Felix J. Bakerindividual, parent holding company | 31.2M | 15.6% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | Julian C. Bakerindividual, parent holding company | 31.2M | 15.6% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | Baker Bros. Advisors LPinvestment adviser, partnership | 30.9M | 15.4% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | Baker Bros. Advisors (GP) LLCparent holding company, other entity | 30.9M | 15.4% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | FBB3 LLCother entity | 31K | 0.0% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | FBB Associatespartnership, other entity | 33K | 0.0% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 33 | FBB2, LLCother entity | 15K | 0.0% | 2026-05-07 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 12.6M | 6.3% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 11 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-10 | 13G | STATE STREET CORPORATIONparent holding company | 9.7M | 5.0% | 2025-09-30 |
| 2025-10-17 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 15.2M | 7.8% | 2025-09-30 |
13F holders
Tracked managers holding INCY at their latest 13F. JSON8 of the 30 tracked managers held INCY at their latest 13F, $1.29B in total at quarter-end prices. AQR Capital Management is the largest at $603.2M (0.2% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 5.3M | $603.2M | 0.21% | -487K |
| Renaissance Technologies | 2026-06-30 | 3.5M | $398.1M | 0.55% | -139K |
| Two Sigma Investments | 2026-06-30 | 2.0M | $227.1M | 0.16% | +1.6M |
| Bridgewater Associates | 2026-06-30 | 168K | $19.1M | 0.08% | +38K |
| Citadel Advisors | 2026-06-30 | 144K | $16.3M | 0.00% | +94K |
| Fisher Asset Management | 2026-06-30 | 137K | $15.5M | 0.00% | +24K |
| Millennium Management | 2026-06-30 | 83K | $9.4M | 0.00% | -90K |
| D. E. Shaw & Co. | 2026-06-30 | 4K | $455K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 FY 2026 (quarter ended 2026-03-31) Incyte reported revenue of $1.27B, up 20.9% from the same quarter a year earlier, and net income of $303.3M (1.47 diluted EPS). In FY 2025 it generated $1.41B of operating cash flow.
- Cash
- $3.46B
- Equity
- $5.62B
- Total assets
- $7.34B
- Shares outstanding
- 199,782,155
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 FY 2026 | 2026-03-31 | $1.27B | $303.3M | 23.8% | 1.47 |
| Q4 FY 2025derived | 2025-12-31 | $1.51B | $299.3M | 19.9% | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.37B | $424.2M | 31.1% | 2.11 |
| Q2 FY 2025 | 2025-06-30 | $1.22B | $405.0M | 33.3% | 2.04 |
| Q1 FY 2025 | 2025-03-31 | $1.05B | $158.2M | 15.0% | 0.80 |
| Q4 FY 2024derived | 2024-12-31 | $1.18B | $201.2M | 17.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $1.14B | $106.5M | 9.4% | 0.54 |
| Q2 FY 2024 | 2024-06-30 | $1.04B | -$444.6M | -42.6% | -2.04 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5.14B | $1.29B | $1.41B | n/a | $0 | n/a |
| FY 2024 | 2024-12-31 | $4.24B | $32.6M | $335.3M | n/a | $2.00B | n/a |
| FY 2023 | 2023-12-31 | $3.70B | $597.6M | $496.5M | n/a | $0 | n/a |
| FY 2022 | 2022-12-31 | $3.39B | $340.7M | $969.9M | $77.8M | $0 | n/a |
| FY 2021 | 2021-12-31 | $2.99B | $948.6M | $749.5M | $181.0M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-03-31; shares outstanding as of 2026-04-21 from the cover page.
What this page is
Incyte in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Incyte (INCY), SEC CIK 879169, listed on Nasdaq, classified by the SEC as services-commercial physical & biological research. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-10.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-03-31.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-28.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 879169Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-commercial physical & biological research
Other company pages
Datasets
Frequently Asked Questions
How much of INCY is sold short?
9,987,084 shares were held short at the 2026-09-30 settlement, 6.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is INCY's daily short volume?
On 2026-10-09, 313,519 of the 458,893 INCY shares reported to FINRA were sold short, 68.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does INCY have fails to deliver?
The SEC's latest file shows 62,826 INCY shares failed to deliver at settlement 2026-09-10. Fails are reported per settlement date and published twice a month with a lag.
Are INCY insiders buying or selling?
Insiders at INCY reported 22 open-market sells worth $18.2M in the last 90 days and no open-market buys. Latest filing: Heeson Lee (EVP, Head of Incyte Intl) on 2026-10-01.
Have INCY insiders filed to sell?
50 Form 144 notices on file for INCY worth $109.2M at the prices reported; 11 in the last 90 days worth $18.2M. Latest: PABLO CAGNONI filed on 2026-09-15 to sell 23,218 shares ($2.8M) from 2026-09-15.
Who owns 5% or more of INCY?
8 holders report 5% or more of INCY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Felix J. Baker at 15.6% of the class (31,225,572 shares), filed 2026-05-11 for an event on 2026-05-07.
What did INCY report last quarter?
In Q1 FY 2026 (quarter ended 2026-03-31) Incyte reported revenue of $1.27B, up 20.9% from the same quarter a year earlier, and net income of $303.3M (1.47 diluted EPS). In FY 2025 it generated $1.41B of operating cash flow.
Which tracked 13F managers own INCY?
8 of the 30 tracked 13F managers held INCY shares at their latest filing, $1.29B in all. The largest: Cliff Asness's AQR Capital Management (5.3M shares, $603.2M), Renaissance Technologies (3.5M shares, $398.1M), Two Sigma Investments (2.0M shares, $227.1M), Ray Dalio's Bridgewater Associates (168K shares, $19.1M), Ken Griffin's Citadel Advisors (144K shares, $16.3M), Ken Fisher's Fisher Asset Management (137K shares, $15.5M). The table above lists all 8.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.